SCHEMBL3473416

SCHEMBL3473416

CCOC(=O)c1cc(OC)c(OC)cc1OCC[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 3/20 0.47
GAA P10253 2/20 0.47
MAPT P10636 4/20 0.46
DPP4 P27487 5/20 0.43
FDPS P14324 1/20 0.41
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
HPGD P15428 2/20 0.40
GALR2 O43603 1/20 0.40
MITF O75030 1/20 0.40
POLB P06746 1/20 0.40
HSP90AA1 P07900 1/20 0.40
XBP1 P17861 1/20 0.40
CCR6 P51684 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3471737 0.88 KMT2A (0.48) KMT2AALDH1A1GAAMAPTLMNA
SCHEMBL3471175 0.81 KMT2A (0.56) KMT2AALDH1A1GAAMAPTDPP4
SCHEMBL2333730 0.76 HTT (0.59) KMT2AALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL2900687 0.76 KMT2A (0.65) KMT2AALDH1A1GAAMAPTDPP4
SCHEMBL5500527 0.76 HTT (0.53) KMT2AALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL13168044 0.75 PKM (0.50) KMT2AALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL8263297 0.75 MEN1 (0.55) KMT2AALDH1A1MAPTDPP4LMNA
SCHEMBL10118722 0.74 PKM (0.49) KMT2AALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL7719088 0.74 PKM (0.49) KMT2AALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL18417238 0.73 KMT2A (0.54) KMT2AALDH1A1GAADPP4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102746242-A Synthesis method of 6, 7-substituent-4-aniline quinazoline OMEGA CO LTD 2012-10-24 CN disclosed
CN-101863844-B Synthesis method of 6, 7-substituent-4-aniline quinazoline XIANGZHEN BIOLOGY TECHNOLOGY CO LTD 2012-10-03 CN disclosed
US-20100267949-A1 Method of Synthesizing 6,7-Substituted 4-Anilino Quinazoline OMEGA MEDICAL TAIWAN LIMITED (TW) 2010-10-21 US disclosed
CN-101863844-A Synthesis method of 6, 7-substituent-4-aniline quinazoline XIANGZHEN BIOLOGY TECHNOLOGY CO LTD 2010-10-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267949-A1 Method of Synthesizing 6,7-Substituted 4-Anilino Quinazoline NQO2, ATIC, CYP3A7 KMT2A 2686/4885ALDH1A1 878/4885GAA 927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.